Member of Lyonbiopole
GeNeuro develops treatments against neurodegenerative and autoimmune diseases by neutralizing harmful Human Endogenous Retrovirus proteins (HERVs). 8% of human DNA possesses a viral origin, left by the viruses that infected our ancestors.
Strategic application domain: Human Medicine
Application market: Neurology & Mental Health Disorders
Type of activity: Therapeutics, Pharma or Biotech
Technologies: Antibodies - Protein - Peptide
Created on feb. 18th, 2009 - 8 employees
Address
60 avenue de Rockefeller 69008 Lyon
Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.